Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Artiva Biotherapeutics, Inc. | 77,500 | reported | 18 May 2026 | tx 3+323,750 |
| Contineum Therapeutics, Inc. | 14,750 | reported | 26 Jun 2025 | tx 2+44,250 |
| Ohr Pharmaceutical Inc | 14,634 | reported | 09 Sept 2020 | tx 2+241,964 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 May 2026 | GRANT_AWARD | Artiva Biotherapeutics, Inc. | 77,500 | 0.00 USD | |
| 18 May 2026 | GRANT_AWARD | Artiva Biotherapeutics, Inc. | 232,500 | 0.00 USD | deriv |
| 24 Jun 2025 | GRANT_AWARD | Artiva Biotherapeutics, Inc. | 13,750 | 0.00 USD | deriv |
| 26 Jun 2025 | GRANT_AWARD | Contineum Therapeutics, Inc. | 14,750 | 0.00 USD | deriv |
| 14 Mar 2025 | GRANT_AWARD | Contineum Therapeutics, Inc. | 29,500 | 0.00 USD | deriv |
| 09 Sept 2020 | GRANT_AWARD | Ohr Pharmaceutical Inc | 14,634 | 0.00 USD | deriv |
| 12 Jul 2019 | GRANT_AWARD | Ohr Pharmaceutical Inc | 227,330 | 0.00 USD | deriv |